Healthy high growth potential
Risultati
8
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
8 aziende
| Azienda | Ultimo prezzo | Ritorno 7D | Ritorno a 1 anno | Cap. di mercato | Obiettivo degli analisti | Valutazione | Crescita | Rendimento del dividendo | ||
|---|---|---|---|---|---|---|---|---|---|---|
1768 | HK$414.00 | 5.1% | n/a | HK$90.2b | HK$549.03 | 33.2 | 30.7% | n/a | ||
003010 | CN¥29.88 | 12.7% | -32.0% | CN¥9.2b | CN¥45.04 | 38.2 | 34.7% | 2.0% | ||
APOTEA | SEK 75.30 | 1.9% | -28.5% | SEK 7.8b | SEK 92.50 | 31.9 | 22.0% | 0.8% | ||
2586 | JP¥79.00 | -1.3% | -72.9% | JP¥9.1b | n/a | 3.5 | 104.9% | n/a | ||
PCRX | CA$0.49 | -2.0% | 0% | CA$85.3m | CA$0.67 | 3.1 | 167.4% | n/a | ||
2517 | HK$1.73 | -6.5% | -49.0% | HK$4.4b | HK$3.88 | 8.2 | 22.7% | 7.4% | ||
PMED | €5.60 | -3.4% | n/a | €42.2m | €7.85 | 6.3 | 36.6% | n/a | ||
GOUR | ج.م16.28 | 4.0% | n/a | ج.م6.5b | ج.م15.23 | 27.9 | 23.5% | 1.3% |
Page 1 of 1